Page 24 - Stephen Schultz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(2) Highlights include continued progress with phase IIb psilocybin therapy clinical trial, launch of first Centre of Excellence, and expansion of Discovery Center Phase IIb clinical trial of COMP360 psilocybin therapy for treatment-resistant depression (TRD) on track to report data by end of 2021 First Centre of Excellence, a research facility and innovation lab, established at Sheppard Pratt (Baltimore, Maryland, US) Discovery Center expanded into network of world-leading scientists developing new optimised psychedelic compounds Conference call today at 1.00pm GMT (8.00am ET) LONDON, March...

Greenlight eyes 2021 expansion as it moves into more areas Brian Sharp, Rochester Democrat and Chronicle © Provided photo Greenlight Networks has moved into new headquarters offices from University Avenue in Rochester to a larger space on East Henrietta Road in Henrietta. Greenlight Networks is freshly ensconced in its new Henrietta headquarters, hiring and looking for a busy year ahead. "You are going to see a lot more activity out of us," President and CEO Mark Murphy said in an interview Tuesday. The company plans to be into the North Winton Village neighborhood in the c...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. COMPASS Pathways expands its Discovery Center through new collaborations with world-leading ... Compass PathwaysFebruary 9, 2021 GMT COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to develop new psychedelic compounds at the virtual Discovery Center London, UK – 9 February 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating pat...

COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy COMPASS Pathways announces publication in of paper on therapist training programme for psilocybin therapy Formal and scalable methodology for psychological support in psilocybin therapy London, UK 3 February 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has shared details of its comprehensive and rigorous therapist … COMPASS Pathways announces publication in Fronti...

Compass Pathways: COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy Frontiers in Psychiatry Formal and scalable methodology for psychological support in psilocybin therapy London, UK - 3 February 2021 COMPASS Pathways plc today. The programme sets out a formal and scalable methodology for psychological support in psilocybin therapy. It is currently being used to train therapists taking part in COMPASS's phase IIb clinical trial of COMP360 psilocybin therapy for treatment-resistant depression, as approved by the U...